SPONSOR
Peking University
Total Trials
7
Recruiting
7
Phases
Phase 2, Phase 3, Phase 1
Conditions studied: HER2-positive Breast CancerBreast CancerDepression, AnxietyEmotional DisordersAutism Spectrum DisordersEsophageal Squamous Cell CarcinomaAdvanced Solid TumorDepressionBipolar Affective DisorderSchizophenia Disorder
NCT04481932 Phase 2
Recruiting
Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer
HER2-positive Breast Cancer
NCT02535221 Phase 3
Recruiting
Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer
Breast Cancer
NCT07280481
Recruiting
Weekly Dynamics of Psychopathological and Symptom Networks During Mindfulness-Based Interventions for Emotional Distress
Depression, Anxiety
NCT06147141
Recruiting
Effectiveness and Mechanism of Online Peer Companion Intervention on Children With Autism Spectrum Disorders
Autism Spectrum Disorders
NCT06684600 Phase 2
Recruiting
Study of Dalpiciclib Isethionate Plus Pyrotinib Maleate in the Treatment of Advanced Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma
NCT06170294 Phase 1
Recruiting
MAGE-A4-directed TCR-T in the Treatment Amongst Subjects With Advanced Solid Tumors
Advanced Solid Tumor
NCT06831435
Recruiting
Effectiveness of Digital Cognitive Behavioral Therapy for the Treatment of Depression: a Real-world Study
Depression